Jpmorgan Chase & CO Organovo Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 40 shares of ONVO stock, worth $13. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 73
45.21%
Holding current value
$13
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ONVO
# of Institutions
34Shares Held
2.44MCall Options Held
17KPut Options Held
0-
Armistice Capital, LLC New York, NY1.22MShares$414,1200.01% of portfolio
-
Prescott Group Capital Management, L.L.C. Tulsa, OK414KShares$140,7710.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA347KShares$118,1450.0% of portfolio
-
Black Rock Inc. New York, NY142KShares$48,3500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA125KShares$42,6620.0% of portfolio
About ORGANOVO HOLDINGS, INC.
- Ticker ONVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,712,020
- Market Cap $2.96M
- Description
- Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...